iShares China Large-Cap ETF (FXI) › Analysis

iShares China Large-Cap ETF (FXI) stock analysis, October 1, 2026: FXI drops 6.79% to $34.02 even as global funds turn neutral on China

Published October 1, 2026 · FXI chart, levels and live analysis

Key Updates

FXI has declined 6.79% since the August 1 report, trading at $34.02 as of October 1, 2026, erasing a significant portion of the recovery observed in late July. YTD losses have widened to -11.15%, compared to -4.67% at the last update, marking a clear reversal of the prior upward momentum. The pullback occurs despite a notable shift in global fund positioning — active long-only managers have ended a four-year underweight stance on Chinese equities to benchmark-neutral — and sustained retail demand for U.S. assets via QDII quotas, which were raised to a record $183 billion.

Current Trend

FXI is in a renewed downtrend over the past month (-3.82%) and six months (-2.80%), with the 5-day decline of -0.99% indicating continued near-term weakness. The price action since the August peak of $36.50 shows a consistent lower-high structure, with the current level of $34.02 sitting notably below the prior consolidation zone. YTD performance of -11.15% places the fund firmly in negative territory, contrasting with the brief rebound seen in late July. The recent price action suggests that the recovery attempt has failed, and the market is retesting lower support levels around the $34.00 area, which aligns with the July trough of $31.59 as a critical downside reference.

Investment Thesis

The investment thesis for FXI centers on a structural reform story in Chinese capital markets, supported by record dividends and buybacks (RMB5.23 trillion in 2024-2025) and a regulatory push to balance fundraising with investor returns. The recent shift by global funds to a benchmark-neutral China allocation — the first in four years — adds institutional validation to the thesis, driven by AI prospects and attractive valuations. However, persistent capital flight (net outflows of $146 billion in Q1 2026) and weak domestic yields continue to pressure the market. The thesis hinges on whether market reforms can attract sustained inflows despite ongoing macro headwinds, with the current price decline suggesting that investors remain cautious about near-term catalysts.

Thesis Status

The thesis remains intact but faces increased pressure. The structural reforms highlighted in the PR Newswire article (September 10) — including the Nine-Point Guideline and a standing stabilization framework — provide a credible long-term foundation. The Bank of America data (September 28) showing neutral allocation is a positive development that had not been priced in at the last report. However, the -6.79% price decline since August indicates that these fundamental improvements have not yet translated into sustained market momentum. The thesis status is "constructive but unconfirmed" — the fundamental case for gradual appreciation remains, but the market is demanding stronger evidence of capital flow reversal before rewarding the narrative.

Key Drivers

Technical Analysis

FXI is trading at $34.02, down 6.79% from the August 1 level of $36.50. The price has broken below the 50-day moving average and is approaching the psychological $34.00 level. Key support is identified at $31.59 (the July trough), with intermediate support at $33.00. Resistance levels are at $35.65 (the July 29 peak) and $36.50 (the August high). The 1-month decline of -3.82% and 5-day decline of -0.99% indicate that selling pressure persists, and the price action shows no clear reversal pattern. A break below $31.59 would signal a retest of YTD lows, while a move above $35.65 would suggest a failed breakdown and potential consolidation.

Bull Case

Bear Case

Get a message when the FXI picture changes — the agent team watches the levels and the news for you.Create a free account

More FXI analyses